Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

The Angels Initiative

Stroke prevention

  Valvular Heart Disease

  Free Subscription

Articles published in Clin Cardiol

Retrieve available abstracts of 36 articles:
HTML format

Single Articles

    September 2022
  1. HIBINO M, Dhingra NK, Chan V, Mazer CD, et al
    Stage-based approach to predict left ventricular reverse remodeling after mitral repair.
    Clin Cardiol. 2022;45:921-927.
    PubMed     Abstract available

    August 2022
  2. YAN J, Liu M, Zhang Y, Yang D, et al
    Comparison of efficacy and safety between VKAs and DOACs in patients with atrial fibrillation after transcatheter aortic valve replacement: A systematic review and meta-analysis.
    Clin Cardiol. 2022 Aug 28. doi: 10.1002/clc.23909.
    PubMed     Abstract available

  3. WALPOT J, van Herck P, Collas V, Bossaerts L, et al
    Adiponectin serum level is an independent and incremental predictor of all-cause mortality after transcatheter aortic valve replacement.
    Clin Cardiol. 2022 Aug 6. doi: 10.1002/clc.23892.
    PubMed     Abstract available

    June 2022
  4. YU J, Qiao E, Wang W
    Mechanical or biologic prostheses for mitral valve replacement: A systematic review and meta-analysis.
    Clin Cardiol. 2022 Jun 5. doi: 10.1002/clc.23854.
    PubMed     Abstract available

    April 2022
  5. VOIGT I, Boeckmann M, Bruder O, Wolf A, et al
    A deep neural network using audio files for detection of aortic stenosis.
    Clin Cardiol. 2022 Apr 19. doi: 10.1002/clc.23826.
    PubMed     Abstract available

    March 2022
  6. HOU J, Sun Y, Zhang L, Wang W, et al
    Assessing left atrial function in patients with atrial fibrillation and valvular heart disease using cardiovascular magnetic resonance imaging.
    Clin Cardiol. 2022 Mar 15. doi: 10.1002/clc.23811.
    PubMed     Abstract available

    February 2022
  7. CHEN YF, Liu F, Li XW, Zhang HJ, et al
    Non-vitamin K oral anticoagulants versus vitamin K antagonists in post transcatheter aortic valve replacement patients with clinical indication for oral anticoagulation: A meta-analysis.
    Clin Cardiol. 2022 Feb 22. doi: 10.1002/clc.23793.
    PubMed     Abstract available

  8. HWANG JW, Kim DG, Kim H, Kwak JJ, et al
    Impact of chronic kidney disease on clinical outcomes in patients with Stage B progressive aortic regurgitation (mild to moderate and moderate grades).
    Clin Cardiol. 2022 Feb 16. doi: 10.1002/clc.23792.
    PubMed     Abstract available

  9. KHALID N, Ahmad SA, Butt N, Kayani WT, et al
    Transcatheter aortic valve implantation in patients with chronic obstructive pulmonary disease.
    Clin Cardiol. 2022;45:149.

    November 2021
  10. MAI Z, Guan L, Mu Y
    Association between bicuspid aortic valve phenotype and patterns of valvular dysfunction: A meta-analysis.
    Clin Cardiol. 2021 Nov 3. doi: 10.1002/clc.23736.
    PubMed     Abstract available

    October 2021
  11. YU S, Zhang S, Yao C, Liu J, et al
    Effects of single versus dual antiplatelet therapy on the adverse events after transcatheter aortic valve implantation: A meta-analysis.
    Clin Cardiol. 2021 Oct 19. doi: 10.1002/clc.23731.
    PubMed     Abstract available

  12. LI P, Xue Y, Sun J, Chen M, et al
    Outcome of alcohol septal ablation in mildly symptomatic patients with hypertrophic obstructive cardiomyopathy: A comparison with medical therapy.
    Clin Cardiol. 2021;44:1409-1415.
    PubMed     Abstract available

    September 2021
  13. MCCALMONT G, Durand E, Lauck S, Muir DF, et al
    Setting a benchmark for resource utilization and quality of care in patients undergoing transcatheter aortic valve implantation in Europe-Rationale and design of the international BENCHMARK registry.
    Clin Cardiol. 2021 Sep 9. doi: 10.1002/clc.23711.
    PubMed     Abstract available

    August 2021
  14. XIANG B, Ma W, Yan S, Chen J, et al
    Rhythm outcomes after aortic valve surgery: Treatment and evolution of new-onset atrial fibrillation.
    Clin Cardiol. 2021 Aug 14. doi: 10.1002/clc.23703.
    PubMed     Abstract available

    July 2021
  15. MAEDER MT, Weber L, Weilenmann D, Chronis J, et al
    Impact of the new pulmonary hypertension definition on long-term mortality in patients with severe aortic stenosis undergoing valve replacement.
    Clin Cardiol. 2021 Jul 4. doi: 10.1002/clc.23685.
    PubMed     Abstract available

    May 2021
  16. LEE WC, Fang HY, Chen HC, Chen YL, et al
    Progressive tricuspid regurgitation and elevated pressure gradient after transvenous permanent pacemaker implantation.
    Clin Cardiol. 2021 May 26. doi: 10.1002/clc.23656.
    PubMed     Abstract available

  17. KAIHARA T, Higuma T, Izumo M, Kotoku N, et al
    Influence of coronary artery disease and percutaneous coronary intervention on mid-term outcomes in patients with aortic valve stenosis treated with transcatheter aortic valve implantation.
    Clin Cardiol. 2021 May 25. doi: 10.1002/clc.23655.
    PubMed     Abstract available

    April 2021
  18. NIE C, Zhu C, Xiao M, Yang Q, et al
    Mid-ventricular obstruction is associated with non-sustained ventricular tachycardia in patients with hypertrophic obstructive cardiomyopathy.
    Clin Cardiol. 2021;44:555-562.
    PubMed     Abstract available

    March 2021
  19. DIXIT NM, Nsair A, Calfon Press MA
    Should SGLT2i be used prior to transcatheter edge-to-edge repair for secondary mitral regurgitation?
    Clin Cardiol. 2021 Mar 27. doi: 10.1002/clc.23603.

  20. DOLDI PM, Brinkmann I, Orban M, Stolz L, et al
    Percutaneous edge-to-edge repair of severe mitral regurgitation using the MitraClip XTR versus NTR system.
    Clin Cardiol. 2021 Mar 24. doi: 10.1002/clc.23599.
    PubMed     Abstract available

    January 2021
  21. CHO IJ, Jeong H, Chang HJ
    Prognostic value of left atrial volume index in patients with rheumatic mitral stenosis.
    Clin Cardiol. 2021 Jan 6. doi: 10.1002/clc.23544.
    PubMed     Abstract available

    December 2020
  22. MEINDL C, Paulus M, Koller T, Rogalski D, et al
    Acquired von Willebrand syndrome and factor VIII in patients with moderate to severe mitral regurgitation undergoing transcatheter mitral valve repair.
    Clin Cardiol. 2020 Dec 29. doi: 10.1002/clc.23538.
    PubMed     Abstract available

  23. KHALID N, Ahmad SA, Butt N, Kayani WT, et al
    Transcatheter aortic valve implantation in patients with chronic obstructive pulmonary disease.
    Clin Cardiol. 2020 Dec 1. doi: 10.1002/clc.23523.

    November 2020
  24. RANDALL MH, Lewandowski TJ, Choi C, Beaver TM, et al
    Valve-in-valve transcatheter aortic valve replacement to treat multijet paravalvular regurgitation: A case series and review.
    Clin Cardiol. 2020 Nov 20. doi: 10.1002/clc.23504.
    PubMed     Abstract available

  25. HAMMADAH M, Ponce C, Sorajja P, Cavalcante JL, et al
    Point-of-care ultrasound: Closing guideline gaps in screening for valvular heart disease.
    Clin Cardiol. 2020 Nov 11. doi: 10.1002/clc.23499.
    PubMed     Abstract available

    October 2020
  26. XIAO F, Yang J, Fan R
    Effects of COPD on in-hospital outcomes of transcatheter aortic valve implantation: Results from the National Inpatient Sample database.
    Clin Cardiol. 2020 Oct 22. doi: 10.1002/clc.23475.
    PubMed     Abstract available

    September 2020
  27. BAVRY AA, Okuno T, Aalaei-Andabili SH, Kumbhani DJ, et al
    The relationship between baseline diastolic dysfunction and postimplantation invasive hemodynamics with transcatheter aortic valve replacement.
    Clin Cardiol. 2020 Sep 22. doi: 10.1002/clc.23457.
    PubMed     Abstract available

  28. ZHANG D, Mao X, Liu D, Zhang J, et al
    Transcatheter vs surgical aortic valve replacement in low to intermediate surgical risk aortic stenosis patients: A systematic review and meta-analysis of randomized controlled trials.
    Clin Cardiol. 2020 Sep 14. doi: 10.1002/clc.23454.
    PubMed     Abstract available

  29. ELZENEINI M, Assaf Y, Aalaei-Andabili SH, Mahmoud A, et al
    Predictors of ventricular pacing burden after permanent pacemaker implantation following transcatheter aortic valve replacement.
    Clin Cardiol. 2020 Sep 4. doi: 10.1002/clc.23447.
    PubMed     Abstract available

    June 2020
  30. HU X, Jiang W, Xie M, Guo R, et al
    Bioprosthetic vs mechanical mitral valve replacement for infective endocarditis in patients aged 50 to 69 years.
    Clin Cardiol. 2020 Jun 4. doi: 10.1002/clc.23407.
    PubMed     Abstract available

    May 2020
  31. TAFELMEIER M, Baessler A, Wagner S, Unsoeld B, et al
    Design of the SILICOFCM study: Effect of sacubitril/valsartan vs lifestyle intervention on functional capacity in patients with hypertrophic cardiomyopathy.
    Clin Cardiol. 2020;43:430-440.
    PubMed     Abstract available

  32. YANG H, Yang Y, Xue Y, Luo S, et al
    Efficacy and safety of radiofrequency ablation for hypertrophic obstructive cardiomyopathy: A systematic review and meta-analysis.
    Clin Cardiol. 2020;43:450-458.
    PubMed     Abstract available

    February 2020
  33. NISSINEN M, Lehto J, Biancari F, Nieminen T, et al
    Preoperative paroxysmal atrial fibrillation predicts high cardiovascular mortality in patients undergoing surgical aortic valve replacement with a bioprosthesis: CAREAVR study.
    Clin Cardiol. 2020 Feb 5. doi: 10.1002/clc.23329.
    PubMed     Abstract available

    January 2020
  34. TIAN Z, Li T, Ma S
    Impact of leaflet thrombosis on hemodynamics and clinical outcomes after bioprosthetic aortic valve replacement: A meta-analysis.
    Clin Cardiol. 2020 Jan 20. doi: 10.1002/clc.23331.
    PubMed     Abstract available

  35. LIU L, Zhang J, Peng Y, Shi J, et al
    Learning curve for transcatheter aortic valve replacement for native aortic regurgitation: Safety and technical performance study.
    Clin Cardiol. 2020 Jan 11. doi: 10.1002/clc.23332.
    PubMed     Abstract available

    December 2019
  36. GALATAS C, Afilalo J
    Transcatheter aortic valve replacement over age 90: Risks vs benefits.
    Clin Cardiol. 2019 Dec 16. doi: 10.1002/clc.23310.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Valvular Heart Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.